当前位置：
X-MOL 学术
›
Blood Cancer J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
Blood Cancer Journal ( IF 12.8 ) Pub Date : 2024-04-15 , DOI: 10.1038/s41408-024-01046-2 Thomas Lund , Michael Tveden Gundesen , Annette Juul Vangsted , Carsten Helleberg , Einar Haukås , Trine Silkjær , Jon Thor Asmussen , Elena Manuela Teodorescu , Bo Amdi Jensen , Tobias Schmidt Slørdahl , Hareth Nahi , Anders Waage , Niels Abildgaard , Fredrik Schjesvold ,
中文翻译：
对于多发性骨髓瘤，两年后每月使用唑来膦酸治疗可持续预防进行性骨病
更新日期：2024-04-15
Blood Cancer Journal ( IF 12.8 ) Pub Date : 2024-04-15 , DOI: 10.1038/s41408-024-01046-2 Thomas Lund , Michael Tveden Gundesen , Annette Juul Vangsted , Carsten Helleberg , Einar Haukås , Trine Silkjær , Jon Thor Asmussen , Elena Manuela Teodorescu , Bo Amdi Jensen , Tobias Schmidt Slørdahl , Hareth Nahi , Anders Waage , Niels Abildgaard , Fredrik Schjesvold ,
|
中文翻译：
对于多发性骨髓瘤，两年后每月使用唑来膦酸治疗可持续预防进行性骨病
京公网安备 11010802027423号